AptaBio Therapeutics Inc. (293780.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 251.64B |
| Enterprise Value | 239.98B |
| P/E Ratio | -5.83 |
| PEG Ratio | -0.19 |
| Price/Sales Ratio | 28.77 |
| Price/Book Ratio | 2.88 |
| Enterprise/Revenue | 28.03 |
| Enterprise/EBITDA | -6.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -4.73 |
| Operating Margin | -4.44 |
AD
Management Effectiveness
| Return On Assets | -0.38 |
| Return On Equity | -0.45 |
Income Statement
| Revenue | 3.7B |
| Revenue/Share | 158.74 |
| Gross Profit | 874.45M |
| EBITDA | -15.05B |
| Net Income | -16.35B |
| Diluted EPS | -607.49 |
Balance Sheet
| Total Cash | 8.62B |
| Total Cash/Share | 320.41 |
| Total Debt | 4.66B |
| Total Debt/Equity | 0.11 |
| Current Ratio | 1.72 |
| Book Value Per Share | 1,519.52 |
Price History
| 52-Week Change | -43.18 |
| 52-Week High | 11,960 |
| 52-Week Low | 4,350 |
| Moving Average 50 Days | 6,573.4 |
| Moving Average 200 Days | 7,647.4 |
Statistics
| Average Volume | 132,833 |
| Shares Outstanding | 28.09M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | August 24, 2021 |
AD
